Clinic
Geisinger Lewistown Hospital
Geisinger Lewistown Hospital was paid $62K by Medicaid between Jul 2021 and Nov 2024, across 17 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 23% of everything it billed.
33Billing provider infoGEISINGER LEWISTOWN HOSPITAL
MIFFLINTOWN, PA 17059
MIFFLINTOWN, PA 17059
33aNPI1609263946assigned 04/24/2015
33bProvider typeMammography Clinic/Center
28Total paid$62K
24GClaims2,580
24DCodes billed17
24AFirst – last monthJul 2021 – Nov 2024
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official MULL, CINDY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 1,337 | $47K | |
| 2022 | 150 | $4K | |
| 2023 | 595 | $7K | |
| 2024incomplete | 498 | $5K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 23% | 164 | 160 | $14K |
| 80053 | Comprehensive metabolic panel | 14% | 691 | 669 | $9K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 12% | 109 | 99 | $7K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 9.7% | 87 | 80 | $6K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 9.4% | 60 | 60 | $6K |
| 84443 | Thyroid stimulating hormone (TSH) | 7.5% | 219 | 211 | $5K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 6.5% | 46 | 46 | $4K |
| 80061 | Lipid panel | 6.1% | 316 | 312 | $4K |
| 83036 | Hemoglobin; glycosylated (A1C) | 4.4% | 454 | 445 | $3K |
| 87631 | 3.5% | 14 | 14 | $2K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.8% | 207 | 194 | $1K |
| 85027 | <1% | 63 | 63 | $486.14 |
5 more codes
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 32 | $330.00 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 29 | $283.32 |
| 71046 | Radiologic examination, chest; 2 views | <1% | 14 | $253.56 |
| 36415 | Collection of venous blood by venipuncture | <1% | 63 | $189.75 |
| 84439 | <1% | 12 | $103.92 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMULL, CINDY (DIRECTOR REVENUE CYCLE)
| Provider | Location | Paid |
|---|---|---|
| Geisinger Clinic | Danville, PA | $74.54M |
| Community Medical Center | Scranton, PA | $22.62M |
| Geisinger Clinic | Danville, PA | $14.93M |
| West Shore Advanced Life Support Services, INC. | Danville, PA | $4.41M |
| Geisinger Clinic | Pottsville, PA | $3.39M |
| Geisinger Clinic | Lewistown, PA | $2.93M |
| Geisinger Clinic | Scranton, PA | $2.63M |
| Geisinger Clinic | Wilkes Barre, PA | $2.35M |
| Geisinger Clinic | Danville, PA | $2.28M |
| Geisinger Jersey Shore Hospital | Jersey Shore, PA | $2.17M |
| Geisinger Clinic | Scranton, PA | $1.71M |
| Geisinger Clinic | Tunkhannock, PA | $1.11M |
| Geisinger Clinic | Orwigsburg, PA | $974K |
| Geisinger Clinic | Pittston, PA | $942K |
| Geisinger Clinic | Berwick, PA | $896K |
| Geisinger Clinic Selinsgrove | Selinsgrove, PA | $819K |
| Geisinger Clinic | Philipsburg, PA | $678K |
| Geisinger Clinic | Lewisburg, PA | $557K |
| Geisinger Clinic | Mountain Top, PA | $523K |
| Geisinger Clinic | Kulpmont, PA | $489K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.